期刊文献+

GS环保试剂在非小细胞肺癌EGFR基因突变检测中的应用 被引量:2

Application of the environmental reagent GS in the detection of EGFR gene mutation in non-small cell lung cancer
下载PDF
导出
摘要 目的探讨GS环保试剂代替二甲苯应用于非小细胞肺癌表皮生长因子受体(epidermal growth factor receptor,EGFR)基因突变检测的效果。方法选取16例确诊为肺腺癌的标本,同一蜡块分别用GS环保脱蜡液、二甲苯进行脱蜡,提取DNA,应用实时荧光定量PCR法检测EGFR基因突变状态。结果GS环保试剂与二甲苯脱蜡同一石蜡标本,GS环保试剂对石蜡切片脱蜡效果良好,标本DNA含量、质量差异无统计学意义(P>0.05),且均符合实时荧光定量PCR要求,且应用实时荧光定量PCR法检测EGFR基因突变状态,其基因突变类型与使用二甲苯脱蜡的检测结果完全一致(符合率100%)。结论GS环保试剂可代替二甲苯应用于非小细胞肺癌EGFR基因突变检测,并符合实验室环保的要求。 Objective To explore the effect of an environmental reagent GS for the detection of epidermal growth factor receptor(EGFR)gene mutation in non-small cell lung cancer instead of xylene.Methods Sixteen specimens of lung adenocarcinoma were selected.The same wax block was dewaxed with environmental reagent GS and xylene respectively,and then DNAs were extracted from the specimens.Real-time fluorescence quantitative PCR was performed to detect the mutation state of EGFR gene.Results The environmental reagent GS had a good dewaxing effect on paraffin-embedded tissue sections compared with xylene.There was no statistical difference in the content and quality of sample DNA between environmental reagent GS and xylene dewaxing(P>0.05).And the content and quality of sample DNA were in accordance with the requirement of real-time fluorescence quantitative PCR.In addition,the detection of the mutation state of EGFR gene was performed using real-time fluorescence quantitative PCR.The types of gene mutation using environmental reagent dewaxing were completely consistent with the results using xylene dewaxing(100%coincidence rate).Conclusion The green reagent dewaxing agent GS can be used in the detection of EGFR gene mutation in non-small cell lung cancer instead of xylene,and it is in accordance with the requirement of the laboratory environmental protection.
作者 魁国菊 禹乐 朱启淦 陈艺锦 杨立民 任红岳 孟加榕 KUI Guoju;YU Le;ZHU Qigan;CHEN Yijin;YANG Limin;REN Hongyue;MENG Jiarong(Department of Pathology,Affiliated Southeast Hospital of Xiamen University,909th Hospital of Joint Logistic Support Force,Zhangzhou 363000,China)
出处 《山西医科大学学报》 CAS 2019年第8期1104-1107,共4页 Journal of Shanxi Medical University
基金 联勤保障部队第九〇九医院院内青年苗圃基金资助项目(17Y015) 联勤保障部队第九〇九医院院内青年苗圃基金资助项目(17Y009) 南京军区联勤第18分部青年培育项目(18FBQN2015008)
关键词 GS环保试剂 二甲苯 脱蜡 非小细胞肺癌 EGFR environmental reagent GS xylene dewaxing non-small-cell lung cancer EGFR
  • 相关文献

参考文献7

二级参考文献56

  • 1HoUen PJ, Gralla RJ, Kris MG, et al. Quality of life assessment in individuals with lung cancer:testing the lung cancer symptom scale (LCSS). Eur J Cancer, 1993, 29(A Suppl 1): 851-858.
  • 2Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.N Engl J Med, 2002, 346(2): 92-98.
  • 3Parra HS, Cavina R,Latteri F, et al. Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer. Br J Cancer, 2004, 91(2): 208-212.
  • 4Kim ES, Hirsh V, Mok T, et al. Getltinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase Ⅲ trial.Lancet, 2008, 372(9652): 1509-1818.
  • 5Shepherd FA, Rodrigues PJ, Ciuleanu T, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med, 2005, 353(2): 123-132.
  • 6Mok TS, Wu YL,Thongprasert S, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med, 2009, 361(10): 1018-1020.
  • 7Chang GC, Tsai CM, Chen KC, et al. Predictive factors ofgefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients. J Thorac Oncol, 2006,1 (6): 520-525.
  • 8Wu YL, Zhong WZ, Li LY, et al. Epidermal growth factor recaptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: a meta-analysis based on updated individual patient data from six medical centers in China's Mainland. J Thorac Oncol, 2007, 2(5): 430-439.
  • 9Reck M, Gatzemeier U. Benefit in lung cancer function improvement and side-effect profile of long-term responders: An analysis of 14 NSCLC patients treated for at least 9 months with gefiUnib. Lung Cancer, 2005, 50(1): 107-114.
  • 10王德田,董健强.实用现代病理学技术[M].北京:中国协和医科大学出版社,2012.

共引文献99

同被引文献20

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部